Oscar Health, Inc. (NYSE:OSCR) Receives $24.00 Consensus Price Target from Brokerages

Shares of Oscar Health, Inc. (NYSE:OSCR) have been given a consensus recommendation of “Hold” by the twelve research firms that are presently covering the stock, Marketbeat.com reports. Eight equities research analysts have rated the stock with a hold recommendation, three have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year target price among analysts that have covered the stock in the last year is $26.2222.

A number of brokerages recently issued reports on OSCR. Weiss Ratings upgraded shares of Oscar Health from a “sell (d+)” rating to a “hold (c+)” rating in a research report on Tuesday, August 11th. UBS Group boosted their price target on shares of Oscar Health from $20.00 to $26.00 and gave the stock a “neutral” rating in a research report on Friday, August 7th. Barclays upped their price target on shares of Oscar Health from $35.00 to $39.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. Wolfe Research started coverage on shares of Oscar Health in a report on Tuesday, May 5th. They issued a “peer perform” rating for the company. Finally, Jefferies Financial Group upgraded shares of Oscar Health from an “underperform” rating to a “hold” rating and raised their price objective for the company from $10.00 to $16.00 in a research note on Monday, April 20th.

Insider Transactions at Oscar Health

In other Oscar Health news, insider Janet Liang sold 12,475 shares of the stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total transaction of $273,701.50. Following the completion of the transaction, the insider directly owned 259,057 shares of the company’s stock, valued at approximately $5,683,710.58. This trade represents a 4.59% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Mario Schlosser sold 147,500 shares of Oscar Health stock in a transaction on Tuesday, June 23rd. The shares were sold at an average price of $29.38, for a total value of $4,333,550.00. Following the transaction, the director owned 1,360,866 shares in the company, valued at approximately $39,982,243.08. This trade represents a 9.78% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 3,562,466 shares of company stock valued at $102,829,815 over the last three months. 22.64% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. BIT Capital GmbH increased its holdings in shares of Oscar Health by 545.0% in the fourth quarter. BIT Capital GmbH now owns 6,186,267 shares of the company’s stock valued at $88,897,000 after buying an additional 5,227,152 shares in the last quarter. Morgan Stanley boosted its stake in shares of Oscar Health by 42.8% during the 4th quarter. Morgan Stanley now owns 6,814,046 shares of the company’s stock worth $97,918,000 after acquiring an additional 2,043,758 shares in the last quarter. Bank of America Corp DE boosted its stake in shares of Oscar Health by 205.1% during the 1st quarter. Bank of America Corp DE now owns 2,860,310 shares of the company’s stock worth $32,808,000 after acquiring an additional 1,922,732 shares in the last quarter. Thrive Capital Management LLC grew its holdings in shares of Oscar Health by 33.4% in the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock worth $85,258,000 after acquiring an additional 1,588,395 shares during the last quarter. Finally, Wedge Capital Management L L P NC acquired a new position in shares of Oscar Health in the 2nd quarter worth $32,855,000. Institutional investors own 75.70% of the company’s stock.

Oscar Health Trading Down 0.2%

Shares of OSCR stock opened at $32.68 on Monday. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.09 and a current ratio of 1.09. Oscar Health has a 1 year low of $10.69 and a 1 year high of $33.27. The stock has a fifty day moving average of $29.65 and a two-hundred day moving average of $20.89. The firm has a market capitalization of $10.09 billion, a PE ratio of 23.34, a price-to-earnings-growth ratio of 0.67 and a beta of 2.36.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Thursday, August 6th. The company reported $1.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.70. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%.The company had revenue of $4.88 billion during the quarter, compared to analysts’ expectations of $4.73 billion. During the same quarter in the prior year, the business posted ($0.89) earnings per share. The company’s revenue for the quarter was up 70.4% compared to the same quarter last year. As a group, research analysts expect that Oscar Health will post 1.54 EPS for the current year.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.